Joseph E. Gilliam - 20 Dec 2024 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Signature
Diana Scherer, Attorney-in-Fact
Issuer symbol
GKOS
Transactions as of
20 Dec 2024
Transactions value $
-$133,929
Form type
4
Filing time
02 Jan 2025, 20:32:38 UTC
Previous filing
01 Nov 2024
Next filing
17 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GKOS Common Stock Tax liability -$134K -964 -0.94% $138.93 101K 20 Dec 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GKOS Stock Option (Right to Buy) Award $0 +7.32K +14.53% $0.00 57.7K 30 Dec 2024 Common Stock 7.32K $55.18 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 18, 2021.
F2 Includes 74,475 restricted stock units that have not yet vested or been delivered to the Reporting Person.
F3 Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors determined that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.
F4 50% of the portion of the option reported herein will vest and become exercisable in March 2025, and the remaining 50% will vest and become exercisable in December 2025.